dr. levy on positive and negative biomarkers for immunotherapy in lung cancer
Published 4 years ago • 202 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:14
dr. levy on investigational biomarkers of response to immunotherapy in nsclc
-
1:13
dr. levy on emerging biomarkers and corresponding therapies in lung cancer
-
2:04
dr. levy on biomarkers of response to immunotherapy
-
1:54
dr. wistuba on biomarkers for immunotherapy in lung cancer
-
1:56
dr. levy on impact of nivolumab, pembrolizumab approvals in nsclc
-
1:24
dr. lilenbaum on pd-l1 as a predictive biomarker for immunotherapy in lung cancer
-
2:56
dr bazhenova on improving biomarker development in lung cancer
-
4:37
emerging biomarkers in lung cancer
-
1:09
dr. levy on first-line treatment for nondriver nsclc
-
1:28
dr. kim on the importance of biomarker testing for lung cancer
-
0:55
dr. levy on the treatment of t790m-mutant lung cancer
-
1:16
dr. suzanne l. topalian on pd-l1 and emerging biomarkers for immunotherapy
-
1:41
dr. goldberg on pd-l1 as a biomarker in lung cancer
-
1:16
dr. levy on treatments for oncogenic-driven nsclc
-
2:01
dr. rimm on biomarker testing in lung cancer
-
2:24
dr. weiss on pd-l1 biomarker in lung cancer
-
1:09
dr. gainor on neoadjuvant use of biomarkers in nonmetastatic lung cancer
-
1:19
dr. chaft on predictive biomarkers in lung cancer
-
1:19
dr. sabari on biomarkers of response to immunotherapy in advanced nsclc